Who Exports Niacin from India — 77 Suppliers Behind a $3.8M Market
India's niacin export market is supplied by 77 active exporters who collectively shipped $3.8M across 396 shipments. AMNEAL PHARMACEUTICALS PRIVATE LIMITED leads with a 36.5% market share, followed by AUROBINDO PHARMA LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 86.0% of total export value, reflecting a concentrated market structure.
Top Niacin Exporters from India — Ranked by Export Value
AMNEAL PHARMACEUTICALS PRIVATE LIMITED is the leading niacin exporter from India, holding a 36.5% share of the $3.8M market across 396 shipments from 77 exporters. The top 5 suppliers — AMNEAL PHARMACEUTICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, AUROBINDO PHARMA LIMITED, MACLEODS PHARMACEUTICALS LTD — collectively control 86.0% of total export value, indicating a highly concentrated market. Individual shares are: AMNEAL PHARMACEUTICALS PRIVATE LIMITED (36.5%), AUROBINDO PHARMA LTD (19.5%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (18.4%), AUROBINDO PHARMA LIMITED (9.7%), MACLEODS PHARMACEUTICALS LTD (2.0%).
Top Niacin Exporters from India
Ranked by export value · 77 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED NIACIN ER TAB 1000 MG NDC 65162-0323-09NIACIN EXTENDED-RELEASE TABLETS 500 MG | $1.4M | 1 | 36.5% |
| 2 | AUROBINDO PHARMA LTD NIACIN ER TAB 1000 MG NDC 65162-0323-09NIACIN EXTENDED-RELEASE TABLETS 500 MG | $738.8K | 1 | 19.5% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED NIACIN ER TAB 1000 MG NDC 65162-0323-09NIACIN EXTENDED-RELEASE TABLETS 500 MG | $694.7K | 1 | 18.4% |
| 4 | AUROBINDO PHARMA LIMITED NIACIN ER TAB 1000 MG NDC 65162-0323-09NIACIN EXTENDED-RELEASE TABLETS 500 MG | $367.8K | 1 | 9.7% |
| 5 | MACLEODS PHARMACEUTICALS LTD NIACIN ER TAB 1000 MG NDC 65162-0323-09NIACIN EXTENDED-RELEASE TABLETS 500 MG | $74.3K | 1 | 2.0% |
| 6 | BABA AGENCIES EXAZEL-N CREAM 15GM (AZELAIC ACID NIACINEXAZEL N CREAM 15GM NOSEXAZEL N CREAM 15GM (AZELAIC ACID NIACIN | $64.6K | 1 | 1.7% |
| 7 | NIBA HEALTHCARE | $55.5K | 3 | 1.5% |
| 8 | TWIN IMPEX HARMLESS MEDICINES NIACINAMIDE BP 15 MG | $44.4K | 1 | 1.2% |
| 9 | LABORATE PHARMACEUTICALS INDIA LTD 306-563 ELVATON DROPS 30ML (NIACIN 2.5MG767-886 VIBEL KID DROPS 30ML (NIACIN 2.5469-669 ELVATON DROPS 30ML(NIACIN 2.5MG, | $31.0K | 2 | 0.8% |
| 10 | ARCO PHARMA PRIVATE LIMITED MULTITONE TABLETS (PCK:10X10TBS | $22.8K | 2 | 0.6% |
| 11 | AHAAN HEALTHCARE PRIVATE LIMITED | $15.1K | 1 | 0.4% |
| 12 | VINAYAK ASSOCIATES | $13.9K | 2 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Niacin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter (January 2 | Yes (September 2023) | Unknown | Not verified | Received FDA warning letter for CGMP deviations; WHO-GMP approval granted in Sep |
| Amneal Pharmaceuticals Private Limited | Warning Letter (August 20 | Unknown | Unknown | Not verified | Received FDA warning letter for laboratory and documentation deficiencies in Aug |
TransData Nexus reviewed the regulatory standing of 2 leading Niacin exporters from India. 0 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 0 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Niacin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma City of India," is a leading hub for pharmaceutical manufacturing and research. The city contributes approximately 40% of India's bulk drug production and houses over 2,000 pharmaceutical companies. Notable firms such as Aurobindo Pharma and Natco Pharma are headquartered here, playing significant roles in the production and export of active pharmaceutical ingredients (APIs) and finished formulations.
The establishment of Genome Valley, a premier biotech cluster, has further bolstered Hyderabad's position in the pharmaceutical sector. This ecosystem supports research, clinical trials, and manufacturing, attracting both national and international companies.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907.
The region's robust infrastructure and skilled workforce have attracted numerous pharmaceutical companies, making it a key player in both domestic and international markets. The presence of multiple USFDA-certified facilities underscores the region's commitment to quality and compliance.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. The region hosts several pharmaceutical companies with manufacturing units and corporate offices, leveraging the logistical advantages for international trade.
The proximity to major ports and international airports enhances the efficiency of supply chains, making this cluster vital for the export-oriented pharmaceutical sector.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical hub, primarily due to favorable tax incentives offered by the government. The region hosts numerous pharmaceutical manufacturing units, contributing substantially to India's pharmaceutical output.
The tax benefits, coupled with supportive infrastructure, have attracted both large and small pharmaceutical companies to set up operations in this zone.
5Sourcing Recommendations
- Diversify Supplier Base: While Amneal Pharmaceuticals Private Limited leads niacin exports, consider engaging with other top exporters like Aurobindo Pharma Ltd and Sun Pharmaceutical Industries Limited to mitigate supply chain risks.
- Evaluate Manufacturing Clusters: Assess the capabilities of suppliers within key pharmaceutical clusters such as Hyderabad and the Ahmedabad-Vadodara corridor to ensure alignment with quality and regulatory standards.
- Leverage Export Gateways: Utilize suppliers in the Mumbai-Thane-Raigad region to benefit from efficient logistics and streamlined export processes.
- Monitor Regulatory Compliance: Ensure that selected suppliers maintain compliance with international regulatory standards, including USFDA certifications, to guarantee product quality and facilitate market access.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Niacin exporters from India
Amneal Pharmaceuticals Private Limited — Amneal invests $200M in new Ahmedabad facilities
Amneal Pharmaceuticals announced a $200 million investment to develop two new facilities in Ahmedabad, India, aimed at producing weight loss drugs. - IMPACT: This expansion may enhance Amneal's production capabilities, potentially affecting its Niacin export capacity.
Impact: This expansion may enhance Amneal's production capabilities, potentially affecting its Niacin export capacity.
Amneal Pharmaceuticals Private Limited — Amneal receives first product approval in China
Amneal Pharmaceuticals received approval to launch its first product in China, Sevelamer carbonate, marking its entry into the Chinese market. - IMPACT: Entry into the Chinese market could diversify Amneal's revenue streams, potentially influencing its focus on Niacin exports.
Impact: Entry into the Chinese market could diversify Amneal's revenue streams, potentially influencing its focus on Niacin exports.
Sun Pharmaceutical Industries Limited — Sun Pharma addresses CDSCO's quality concerns
Sun Pharma refuted claims in the CDSCO report that flagged certain medicines as "counterfeits," asserting that the flagged products were not manufactured by them and that their products meet quality standards. - IMPACT: Maintaining regulatory compliance ensures continued trust in Sun Pharma's products, potentially stabilizing its Niacin export activities.
Impact: Maintaining regulatory compliance ensures continued trust in Sun Pharma's products, potentially stabilizing its Niacin export activities.
Common Questions — Niacin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which niacin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, AMNEAL PHARMACEUTICALS PRIVATE LIMITED leads with 36 recorded shipments worth $1.4M. AUROBINDO PHARMA LTD (40 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (51 shipments) are also established high-volume exporters.
Q How many niacin manufacturers are there in India?
India has 77 active niacin exporters with a combined export market of $3.8M across 396 shipments to 45 countries. The top 5 suppliers hold 86.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for niacin from India?
Average FOB unit price: $4.37 per unit, ranging from $0.00 to $174.56. Average shipment value: $9.6K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 77 verified Indian exporters of Niacin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 396 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 45 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
396 Verified Shipments
77 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists